Rare Disease Summit / Access USA
Conference Focus
Rare disease market access, commercialization, patient engagement
Overview
The Rare Disease Summit / Access USA is a premier industry event organized by Informa Connect, specifically designed to address the unique challenges of commercializing therapies for rare conditions. The conference serves as a critical nexus for stakeholders across the pharmaceutical and biotech sectors, focusing on the complexities of market access, patient advocacy, and regulatory pathways. It provides a platform for leaders to discuss strategies for navigating orphan drug development, pricing, and reimbursement in the US market. What distinguishes this summit is its holistic approach, bridging the gap between clinical development and commercial success. By integrating perspectives from patient advocacy groups, payers, and industry executives, the event offers actionable insights into accelerating patient access to life-changing treatments. It is a vital forum for those shaping the future of rare disease care.
Why Attend
Professionals should attend to gain strategic insights into the evolving US rare disease landscape. The summit offers unparalleled networking with industry peers, payers, and patient advocates, facilitating partnerships that drive commercial success. Attendees will learn best practices for navigating complex reimbursement environments, optimizing patient engagement strategies, and ensuring long-term product viability in the orphan drug space.
Key Topics & Sessions
- •Orphan Drug Market Access Strategies
- •Patient Advocacy and Engagement
- •Pricing and Reimbursement Models
- •Regulatory Pathways for Rare Diseases
- •Real-World Evidence Generation
- •Commercialization of Gene Therapies
- •Health Economics and Outcomes Research (HEOR)
- •Rare Disease Policy and Legislation
- •Patient Support Program Design
- •Launch Excellence in Orphan Drugs
Who Should Attend
Conference History
Organized by Informa Connect, a global leader in life sciences events, this summit has evolved into a cornerstone event for the rare disease community. It has grown alongside the increasing focus on orphan drug development, consistently providing a platform for industry experts to address the shifting regulatory and commercial landscape.
Venue & Location
Sheraton Philadelphia Downtown, located in the heart of Philadelphia, PA, a key hub for the pharmaceutical and biotech industry.
Related Conference Categories
This conference covers topics in the following pharma and life sciences domains. Explore more events in each category using our conference directory filters.
Resources & Links
About Rare Disease Summit / Access USA
Rare Disease Summit / Access USA is a in-person event scheduled for 2026-03-16 to 2026-03-19 in Sheraton Philadelphia Downtown, Philadelphia, PA. The conference focuses on rare disease market access, commercialization, patient engagement. This event is categorized under Commercial & Marketing, Medical Affairs in our conference directory.
The Rare Disease Summit / Access USA is a premier industry event organized by Informa Connect, specifically designed to address the unique challenges of commercializing therapies for rare conditions. The conference serves as a critical nexus for stakeholders across the pharmaceutical and biotech sectors, focusing on the complexities of market access, patient advocacy, and regulatory pathways. It provides a platform for leaders to discuss strategies for navigating orphan drug development, pricing, and reimbursement in the US market. What distinguishes this summit is its holistic approach, bridging the gap between clinical development and commercial success. By integrating perspectives from patient advocacy groups, payers, and industry executives, the event offers actionable insights into accelerating patient access to life-changing treatments. It is a vital forum for those shaping the future of rare disease care.
Professionals attending conferences like Rare Disease Summit / Access USA gain access to cutting-edge insights, peer networking, and exposure to the latest technologies shaping the pharmaceutical and biotechnology sectors. Whether you are evaluating new vendors, seeking regulatory updates, or expanding your professional network, industry conferences remain one of the most effective ways to stay current in life sciences.
Looking for guidance on which conferences to attend or how to build your event strategy for 2026? Book a meeting with the IntuitionLabs team to discuss your priorities and how we can support your team.